Amryt buys Aegerion via bankruptcy, adding sales to support R&D
snippet
Amryt Pharma has completed the acquisition of Aegerion Pharmaceuticals. The deal, which comes after Aegerion filed for Chapter 11 bankruptcy, gives Amryt near-full control of two commercial drugs.
Source
Fierce Biotech